Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6304-6309
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6304
Table 1 Baseline characteristics of patients in the two groups
CharacteristicStudy group(n = 15)Control group(n = 16)P value
Age (yr)42.6 ± 9.940.9 ± 12.60.6806
BMI (kg/m2)27.4 ± 4.128.5 ± 3.70.4387
Sex (male/female), n10/511/51.0000
Bacterial culture positive, n341.0000
Marshall score2.6 ± 1.72.5 ± 1.40.8590
APACHE II score21.3 ± 2.922.5 ± 2.10.1952
Upper gastrointestinal bleeding, n781.0000
ARDS, n12131.0000
Heart failure/pulmonary edema, n320.6539
DIC, n121.0000
Surgical debridement, n111.0000
Use of vasopressors, n15161.0000
Mechanical ventilation, n10101.0000
Table 2 Comparison of secondary outcome measures
VariableStudy groupControl groupP value
Duration of ICU stay (d)7.40 ± 1.359.19 ± 2.990.0420
Time to target TG (d)3.47 ± 0.527.90 ± 1.14< 0.0001
Systemic complications, n (%)9 (60.00)8 (50.00)0.7224
Local complications, n (%)12 (80.00)13 (81.25)1.0000
Table 3 Comparison of physiologic variables
VariableStudy group(n = 15)Control group(n = 16)
Body temperature (°C)37.5 ± 0.637.3 ± 0.4
Heart rate (beats/min)86 ± 1490 ± 19
RR interval (beats/min)16 ± 418 ± 5
Mean arterial pressure (mmHg)70.2 ± 9.367.9 ± 6.0
PaO2/FiO2179.1 ± 41.9167.7 ± 38.9
Table 4 Comparison of laboratory variables
VariableStudy group (n = 15)Control group (n = 16)
WBC (109/L)11.5 ± 2.313.1 ± 2.9
PLT (109/L)196.5 ± 40.5199.6 ± 58.7
ALB (g/L)37.8 ± 4.6a38.9 ± 5.7
ALT (U/L)54.3 ± 20.459.7 ± 23.1
TBIL (mmol/L)20.1 ± 3.925.3 ± 4.2
BUN (mmol/L)7.8 ± 2.69.7 ± 2.8
Scr (mmol/L)149.8 ± 30.2139.3 ± 37.5
Ca2+ (mmol/L)2.1 ± 0.52.0 ± 0.3
Serum amylase (U/L)74.4 ± 28.382.1 ± 20.7
Urine amylase (U/L)399.7 ± 59.7387.1 ± 51.4
CRP (mg/L)20.5 ± 6.4a28.5 ± 7.1
PCT (ng/mL)1.33 ± 0.42a1.71 ± 0.61